Skip to main content
. 2008 Aug 12;66(4):455–466. doi: 10.1111/j.1365-2125.2008.03247.x

Table 1.

Parameter estimates from a healthy study population used as prior information for the sufficient design in patients with HIV infection

Parameter Mean
Pharmacokinetic parameters
 CL (l h−1) 1.18
V (l) 55.7
Ka (h−1) 3.38
Alag (h) 0.23
Between-subject variability CV%
 BSVCL 22.2
 BSVV 17.4
 BSVKa 177.8
Residual variability
 Proportional error (CV%) 14.7
 Additive error (mg l−1) 0.08
 Limit of quantification (mg l−1) 0.2